Pathway
Inhibitors of metabolism in melanoma therapy
No description recorded for this entry yet. Everything this graph holds about Inhibitors of metabolism in melanoma therapy is below.
WP:5609
A pathway is a curated set of reactions that a database groups under one name. Everything the graph places in it is listed below, and each row is a hypothesis about membership rather than a finding.
18 reference statements name it. None connects it directly to a compound with a graded finding, so this page serves and is not indexed — the floor in 80_DISCOVERY §3.
What the reference databases state
Statements
18 statements
18 statements in 1 reference database name Inhibitors of metabolism in melanoma therapy — WikiPathways. Press a relation to see only its rows; every count is the rows behind it.
- ACSS1 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- CPT1A participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- DLAT participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- G6PD participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- GLS participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- GPX4 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- GSR participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- LDHA participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- LDHB participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- MTOR participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- NAMPT participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- PDHA1 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
Show the remaining 6
- PKLR participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- PKM participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- SLC16A1 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- SLC16A3 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- SLC1A5 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- SLC2A1 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only